Urgent.News

What's breaking now, across thousands of outlets.

Business

Fintech funding in Singapore drops to US$499M as dealmaking becomes more selective

Singapore’s fintech market entered 2026 with a familiar contradiction: its strategic appeal remains intact, but capital has become much harder to win. Fintech companies in the city-state raised just over US$499 million across 53 deals in the first half of 2026, according to KPMG’s Pulse of Fintech H1 2026 report. That is a sharp fall […] The post Fintech funding in Singapore drops to US$499M as…

Fintech funding in Singapore drops to US$499M as dealmaking becomes more selective

Singapore's fintech market in 2026 reflected a familiar contradiction - strategic appeal remained strong, but capital became much harder to win. In the first half of 2026, fintech companies in Singapore raised only US$499 million across 53 deals, a significant drop from US$1.45 billion and 97 deals in the same period last year. This marks the weakest first-half fintech investment performance in nearly a decade.

The headline number, however, masks an uneven market, with funding frozen in the first quarter and a rebound in the second quarter heavily dependent on a single US$320 million round for a cross-border payments platform in June.

Written by urgent.news from e27's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at e27.co →

More in Business

Turkey probes Israeli pharmaceutical company Teva over claims it blocked rivals in drug market

The Turkish investigation was opened against Teva International, its subsidiary Teva Europe, and its subsidiary in Turkey to determine whether the law was violated.

  • Turkish Competition Authority investigates Teva for alleged market manipulation.
  • Teva's actions in generic drug sector include patent misuse and misleading health info.
  • Investigation launched against Teva International, Teva Europe, and Teva Turkey subsidiary.

More from Thursday 27 August →